7.3.8. survival. cancers, bladder cancer ranks 13th terms mortality, rates decreasing particularly developed countries . disease-free survival os large population-based study 35% 58% ten years, respectively . however, 5-year os node-positive patients underwent cystectomy 18% . systematic review including 57 studies (n = 30,293) assessed long-term survical patients treated trimodality therapy (tmt) rc . ten-year os 30.9% 35.1%, tmt rc, respectively mean dss 50.9% tmt 57.8% rc. t2 disease, 10-year dss 69% 78.9% tmt rc, respectively t3/t4 disease 43.5% 43.1% tmt rc, respectively. three percent patients (812 27,867) received nac, resulting 5-year os dss downstaged patients (â‰¤ pt1) rc 75.7% 88.3%, respectively.